These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19635930)
1. Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Bem RA; Bos AP; Wösten-van Asperen RM; Bruijn M; Lutter R; Sprick MR; van Woensel JB Am J Respir Cell Mol Biol; 2010 Jun; 42(6):697-705. PubMed ID: 19635930 [TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF. McNamara PS; Fonceca AM; Howarth D; Correia JB; Slupsky JR; Trinick RE; Al Turaiki W; Smyth RL; Flanagan BF Thorax; 2013 Jan; 68(1):76-81. PubMed ID: 23002173 [TBL] [Abstract][Full Text] [Related]
9. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells. Hirakawa S; Kojima T; Obata K; Okabayashi T; Yokota S; Nomura K; Obonai T; Fuchimoto J; Himi T; Tsutsumi H; Sawada N J Med Virol; 2013 Dec; 85(12):2141-50. PubMed ID: 24009192 [TBL] [Abstract][Full Text] [Related]
10. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157 [TBL] [Abstract][Full Text] [Related]
11. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Piedimonte G Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455 [TBL] [Abstract][Full Text] [Related]
12. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Arnold R; Humbert B; Werchau H; Gallati H; König W Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Patel JA; Kunimoto M; Sim TC; Garofalo R; Eliott T; Baron S; Ruuskanen O; Chonmaitree T; Ogra PL; Schmalstieg F Am J Respir Cell Mol Biol; 1995 Nov; 13(5):602-9. PubMed ID: 7576697 [TBL] [Abstract][Full Text] [Related]
16. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Wajant H; Moosmayer D; Wüest T; Bartke T; Gerlach E; Schönherr U; Peters N; Scheurich P; Pfizenmaier K Oncogene; 2001 Jul; 20(30):4101-6. PubMed ID: 11494138 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]